English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Here we describe inhibitory activity of IQG607, pentacyano(isoniazid)ferrate(II), on isoniazid-sensitive and isoniazid-resistant strains of Mycobacterium tuberculosis, oral toxicity, and efforts to adapt IQG607 synthesis to large chemical reactors. IQG607 represents a founding member of a new class of lead compounds aiming at inhibition of a validated and druggable molecular target.Descrevemos a atividade inibitória do IQG607, pentaciano(isoniazida)ferrato(II), frente acepas de Mycobacterium tuberculosis tanto resistentes quanto sensíveis à isoniazida, assim comoa toxicidade oral e a adaptação da síntese química do IQG607 para reatores maiores. O IQG607representa um potencial agente quimioterápico que inibe um alvo molecular definido

journal of the brazilian chemical society

An inorganic complex that inhibits Mycobacterium tuberculosis enoyl reductase as a prototype of a new class of chemotherapeutic agents to treat tuberculosis